Mr. Chris Miller reports
KOIOS ANNOUNCES SHARE CONSOLIDATION
Koios Beverage Corp., pursuant to a directors' resolution, and the receipt of shareholders' approval at the annual general and special meeting held on July 18, 2024, will be consolidating all of its issued and outstanding share capital on the basis of 75 old common shares into one new common share, effective on or about Aug. 21, 2024.
As a result of the share consolidation, the issued and outstanding common shares will be reduced to approximately 1,894,589. No fractional shares will be issued as a result of the share consolidation. All fractions will be rounded down to the next lowest whole number. No cash consideration will be paid in respect of fractional shares. The exercise or conversion price and the number of common shares issuable under any of the company's outstanding convertible securities will be proportionately adjusted upon the share consolidation.
New ISIN: CA5002713090
New Cusip: 500271309
The common shares are expected to begin trading on a postshare consolidation basis on the Canadian Securities Exchange when markets open on Aug. 21, 2024.
Shareholders of record as at the record date will receive a letter of transmittal providing instruction for the exchange for their common shares as soon as practicable following the record date.
The company believes that the share consolidation will make the company more attractive to financing opportunities, and will allow for the restructuring and settlement of certain existing liabilities. Completion of the share consolidation remains subject to completion of appropriate regulatory filings with the Canadian Securities Exchange.
About Koios Beverage Corp.
The company is an emerging functional beverage company which has an available distribution network of more than 5,100 retail locations across the United States in which to sell its products. Koios has relationships with some of the largest and most reputable distributors in the United States, including Europa Sports, Muscle Foods USA, KeHE and Wishing-U-Well. Koios uses a proprietary blend of nootropics and natural organic compounds to enhance human productivity without using harmful chemicals or stimulants. Koios products have been shown to enhance focus, concentration, mental capacity, memory retention, cognitive function, alertness, brain capacity and create all-day mental clarity. Its ingredients are specifically designed to target brain function by increasing blood flow, oxygen levels and neural connections in the brain.
Koios produces one of the only drinks in the world infused with MCT (medium-chain triglycerides) oil. MCT oil is derived from coconuts, and has been shown to help the body burn fat more effectively, create lasting energy from a natural food source, produce ketones in the brain, allowing for greater brain function and clarity, support healthy hormone production, and improve immunity.
We seek Safe Harbor.
© 2025 Canjex Publishing Ltd. All rights reserved.